⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL28753713 | 0.94 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL9293839 | 0.76 | — | — | |
| SCHEMBL4450820 | 0.76 | ALDH1A1 (0.61) | — | |
| SCHEMBL18631359 | 0.75 | — | — | |
| SCHEMBL20497683 | 0.75 | — | — | |
| SCHEMBL18631183 | 0.75 | — | — | |
| SCHEMBL8093699 | 0.74 | CES1 (0.46) | — | |
| SCHEMBL777742 | 0.72 | CA1 (0.35) | — | |
| SCHEMBL11865643 | 0.71 | — | — | |
| SCHEMBL20498944 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2443 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118742289-A | Controlled release implants for biological agents and corresponding methods of treatment | 视尔普斯眼科公司 | 2024-10-01 | — | — | CN | claimed |
| CN-116615556-A | Use of DEXTRAMER in single cell assays | 贝克顿迪金森公司 | 2023-08-18 | — | — | CN | claimed |
| EP-2734537-B1 | POLYPEPTIDE SEPARATION METHODS | ZEPTEON INCORPORATED (US) | 2022-12-21 | — | — | EP | claimed |
| CN-114101012-A | Tresyl-chlorine modified FN (FN) implant micro-groove titanium sheet as well as preparation method and application thereof | 泉州医学高等专科学校 | 2022-03-01 | — | — | CN | claimed |
| CN-113797900-A | Adsorbing material for blood purification, preparation method and application thereof, adsorption column and blood adsorbing device | 广州康盛生物科技股份有限公司 | 2021-12-17 | — | — | CN | claimed |
| CN-111653688-B | Composite material, preparation method thereof and quantum dot light-emitting diode | TCL科技集团股份有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-111653688-A | Composite material, preparation method thereof and quantum dot light-emitting diode | TCL集团股份有限公司 | 2020-09-11 | — | — | CN | claimed |
| EP-2753625-B1 | METHOD FOR THE MANUFACTURE OF COMPOUNDS CONTAINING AN ALPHA-OXYPHOSPHORUS GROUP BY USING AN ACTIVATOR | STRAITMARK HOLDING AG (CH) | 2017-08-02 | — | — | EP | claimed |
| EP-2214732-B1 | MULTIFUNCTIONAL TITANIUM SURFACES FOR BONE INTEGRATION | TORINO POLITECNICO (IT) | 2013-05-15 | — | — | EP | claimed |
| WO-2013065066-A1 | PROCESSES FOR PREPARING 4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6- DIHYDRO [L,2,41-TRIAZOLO[43-A]PYRAZIN-7(8H)-YL]-L-(2,4,5- TRIFLUOROPHENYL)BUTAN-2-AMINE | CADILA HEALTHCARE LIMITED (IN) | 2013-05-10 | — | — | WO | claimed |
| US-20030092905-A1 | Synthesis of [2.2.1]bicyclo nucleosides | EXIQON A/S | 2003-05-15 | — | — | US | claimed |
| EP-1163250-A2 | IMPROVED SYNTHESIS OF [2.2.1]BICYCLO NUCLEOSIDES | Exiqon A/S (DK) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056746-A2 | IMPROVED SYNTHESIS OF [2.2.1]BICYCLO NUCLEOSIDES | EXIQON A/S (US) | 2000-09-28 | — | — | WO | claimed |
| US-5852193-A | Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals | ELI LILLY AND COMPANY (US) | 1998-12-22 | — | — | US | claimed |
| EP-0844243-A1 | Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-05-27 | — | — | EP | claimed |
| EP-0494216-B1 | SURFACES HAVING DESIRABLE CELL ADHESIVE EFFECTS | UNIV TEXAS (US) | 1997-05-14 | — | — | EP | claimed |
| EP-0494216-A1 | SURFACES HAVING DESIRABLE CELL ADHESIVE EFFECTS. | UNIV TEXAS (US) | 1992-07-15 | — | — | EP | claimed |
| WO-1991005036-A2 | SURFACES HAVING DESIRABLE CELL ADHESIVE EFFECTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-04-18 | — | — | WO | claimed |
| EP-0221175-B1 | THERMALLY INDUCED PHASE SEPARATION IMMUNOASSAY | GENETIC SYSTEMS CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |
| US-4415665-A | Method of covalently binding biologically active organic substances to polymeric substances | PHARMACIA FINE CHEMICALS AB (SE) | 1983-11-15 | — | — | US | claimed |